CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Neuland Laboratories Ltd

Neuland Laboratories Ltd

BSE 524558 NEULANDLAB INE794A01010
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 30 trading days

19 filings · 6 material · busiest 2026-08-05

What it files

General4 Analyst / Investor Meet3 AGM / EGM2 Credit Rating1 SAST1 Concall Transcript1 Newspaper Publication1 Board Outcome1

Filings

19 in the window

  1. 25 August 2026

    Credit Rating

    Credit Rating

    Announcement under Regulation 30 (LODR) - Credit Rating

    Company Update / Credit Rating View filing →

  2. 17 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  3. 14 August 2026

    General

    Intimation Regarding Completion Of US FDA Inspection

    Intimation regarding completion of US FDA Inspection

    Company Update / General View filing →

  4. 10 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of the Earnings Call conducted on August 5, 2026

    Company Update / Earnings Call Transcript View filing →

  5. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026

    Company Update / Analyst / Investor Meet View filing →

  6. 6 August 2026

    Newspaper Publication

    Newspaper Publication

    Copy of Newspaper Publication

    Company Update / Newspaper Publication View filing →

  7. 5 August 2026

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026

    Unaudited Financial Results of the Company for the quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  8. 5 August 2026

    Results

    Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026

    Unaudited Financial Results of the Company for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  9. 5 August 2026

    Press Release

    Press Release / Media Release

    Press Release on the Financial Results of the Company for the quarter ended June 30, 2026

    Company Update / Press Release / Media Release View filing →

  10. 5 August 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026

    Company Update / Investor Presentation View filing →

  11. 5 August 2026

    General

    Disclosure Under Regulation 30 Of SEBI Listing Regulations

    Disclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee

    Company Update / General View filing →

  12. 5 August 2026

    General

    Disclosure Under Regulation 30 Of SEBI Listing Regulations

    Disclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity

    Company Update / General View filing →

  13. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of the Earnings call conducted on August 5, 2026

    Company Update / Analyst / Investor Meet View filing →

  14. 4 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Voting Results, Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4, 2026

    AGM/EGM / AGM View filing →

  15. 4 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results, Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4, 2026

    AGM/EGM / AGM View filing →

  16. 31 July 2026

    General

    Intimation Under Regulation 30 Of SEBI Listing Regulations

    Intimation under Regulation 30 of SEBI Listing Regulations

    Company Update / General View filing →

  17. 28 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Q1FY27 Earnings Call Intimation

    Company Update / Analyst / Investor Meet View filing →

  18. 20 July 2026

    Duplicate Certificate

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of Loss of Share Certificate(s)

    Others / Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate View filing →

  19. 20 July 2026

    Board Meeting

    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026

    Neuland Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the unaudited financial ....

    Board Meeting / Board Meeting View filing →